SBC Medical Group Holdings (SBC) risk factors, FY2025 10-K

SBC Medical Group Holdings's FY2025 10-K, filed Mar 27, 2026, lists 83 risk factors in 6 groups. Against the prior year's 77: 8 new, 2 dropped, 26 substantially reworded.

Risk factors listed
836 groups
New this year
8vs 77 last year
Dropped
2since the prior 10-K
Substantially reworded
26of those kept
Section length
23k wordsItem 1A

What the changes say

  • Internal control weaknesses persisted into fiscal year 2025 despite remediation plans.

What changed since the prior 10-K

New

  • NewRisks Relating to Our Business and Industry

    Uncertainties with respect to the development, and use of artificial intelligence in our business and products may result in harm to our business and reputation

    Adopting artificial intelligence risks operational disruptions, biased algorithms, and talent shortages.

  • NewRisks Relating to Our Business and Industry

    a legal system subject to undue influence or corruption

    International business is vulnerable to legal systems subject to corruption or undue influence.

  • NewRisks Related to Intellectual Property

    establish and maintain alternative branding for our brand and services

    Infringement claims or litigation could impose substantial costs and require alternative branding.

  • NewRisk Relating to Ownership of Our Securities

    other events or factors, including those resulting from pandemics, natural disasters, war, acts of terrorism or responses to these events

    Market volatility from pandemics or war can depress stock price and trigger securities class actions.

  • NewRisk Relating to Ownership of Our Securities

    Our securities holders may face limitations in connection with the issuance of shares upon the exercise of our warrants, and additional state securities law requirements could apply if our securities were to become no longer listed on a national securities exchange

    State blue sky laws could restrict warrant exercises and resale if Nasdaq listing is lost.

  • NewRisk Relating to Ownership of Our Securities

    If a “penny stock” is sold to the investor in a fraudulent manner, the investor may be able to sue the persons and firms that committed the fraud for damages

    Penny stock rules may reduce liquidity, broker-dealer recommendations, and investor demand for our securities.

  • NewRisk Relating to Ownership of Our Securities

    in the case of an issuer whose public float as calculated under paragraph (1) or (2) of this definition was zero or whose public float was less than $700 million, had annual revenues of less than $100 million during the most recently completed fiscal year for which audited financial statements are available

    Smaller reporting company status permits scaled disclosures that may make our stock less attractive.

  • NewRisk Relating to Ownership of Our Securities

    Nothing in the Company’s certificate of incorporation or bylaws will preclude stockholders that assert claims under the Securities Act or the Exchange Act from bringing such claims in state or federal court, subject to applicable law

    Dr. Yoshiyuki Aikawa owns 85.2% of voting power, making us a controlled company with reduced governance protections.

Dropped

  • DroppedRisks Relating to Our Business and Industry

    Our system of internal controls failed to detect this misappropriation of funds due to the following material weaknesses of SBC Medical Group Co., Ltd

  • DroppedRisk Relating to Ownership of Our Securities

    Our securities holders may face significant restrictions on the resale of our securities due to state “Blue Sky” laws

Reworded

  • 99% rewrittenRisks Relating to Our Business and Industry

    Effective internal controls are necessary for us to provide reliable financial reports, prevent fraud and operate successfully as a public company. Section 404 of the Sarbanes-Oxley Act of 2002 requires that companies evaluate and report on their systems of internal control over financial reporting

    Updated to state that material weaknesses regarding related party transactions and executive compensation continued to exist in fiscal year 2025.

  • 71% rewrittenRisk Relating to Ownership of Our Securities

    Provisions in the Amended Charter and Delaware law may have the effect of discouraging lawsuits against the Company and its directors and officers

    Refined wording regarding the exclusive forum provisions under Delaware law and the Amended Charter.

  • 68% rewrittenRisk Relating to Ownership of Our Securities

    The market price of our common stock may decline

    Removed references to the Business Combination and streamlined reasons for stock price decline.

  • 62% rewrittenRisk Relating to Ownership of Our Securities

    There must be a current registration statement in order for you to exercise the Private Placement Warrants

    Added state-level registration and qualification requirements for issuing shares upon Private Placement Warrant exercise.

  • 61% rewrittenRisks Relating to Our Business and Industry

    Our employees, agents, business partners or subcontractors may engage in misconduct or other improper activities, which could cause us to lose contracts, expose us to damages, harm our reputation and diminish investor confidence in our company

    Updated the Japanese subsidiary fund misappropriation description to reference the March 2025 Form 10-K restatement.

  • 60% rewrittenRisks Relating to Our Business and Industry

    Any significant change in the customer reward program at our franchisee and other alliance clinics could have a negative impact on our business

    Updated customer reward program expiration terms to reflect June 1, 2025 revisions and changed exchange rate from $0.0067 to $0.0064.

    Was: Any significant change in the franchisee clinic customer reward program could have a negative impact on our business

  • 56% rewrittenRisk Relating to Ownership of Our Securities

    Delaware law and the Company certificate of incorporation and bylaws contain certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable

    Retained existing anti-takeover and charter restriction disclosures.

    Was: Delaware law and the Company certificate of incorporation and bylaws contains certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable

  • 44% rewrittenRisk Relating to Ownership of Our Securities

    Anti-takeover effects of certain provisions of Delaware state law could hinder a potential takeover of the Company

    Clarified Section 203 of the DGCL restrictions on business combinations with 15% stockholders for a three-year period.

  • 42% rewrittenRisks Relating to Our Business and Industry

    We are subject to risks associated with strategic alliances or acquisitions. If we cannot manage the growth of our business or execute our strategies effectively, our business and prospects may be materially and adversely affected

  • 42% rewrittenRisks Relating to Our Business and Industry

    Any financial or economic crisis or perceived threat of such a crisis may materially and adversely affect our business, financial condition and results of operations

  • 41% rewrittenRisk Relating to Ownership of Our Securities

    We believe we will be considered a smaller reporting company and will be exempt from certain disclosure requirements, which could make our common stock less attractive to potential investors

  • 33% rewrittenRisks Related to Intellectual Property

    Our or our subsidiaries’ intellectual property rights may not protect us effectively

  • 32% rewrittenRisks Relating to Our Business and Industry

    Failure to safeguard personal information could subject us to penalties, damage our reputation and brand, and harm our business and results of operations

  • 30% rewrittenRisk Relating to Ownership of Our Securities

    As an emerging growth company, our auditor is not required to attest to the effectiveness of our internal controls

  • 29% rewrittenRisks Relating to Our Business and Industry

    Safety issues or public perceptions of safety issues concerning cosmetic services could have a material adverse impact on our business

  • 26% rewrittenRisks Related to Intellectual Property

    We and our subsidiaries may need to defend ourselves against claims of intellectual property infringement, which may be time-consuming and costly

  • 26% rewrittenGeneral Risks

    We are exposed to fluctuations in currency exchange rates

  • 26% rewrittenRisks Relating to Our Business and Industry

    The financial performance of our franchisees and other alliance partners can negatively impact our business

    Was: The financial performance of our franchisees can negatively impact our business

  • 24% rewrittenRisk Relating to Ownership of Our Securities

    In the event that our common stock price does not exceed the exercise price of the Private Placement Warrants during the period when the Private Placement Warrants are exercisable, the Private Placement Warrants may not have any value

  • 24% rewrittenRisks Relating to Our Business and Industry

    We may need additional capital, and we cannot be sure that additional financing will be available

  • 24% rewrittenRisk Relating to Ownership of Our Securities

    The market price of our common stock may be volatile, and you could lose all or part of your investment

  • 23% rewrittenRisks Relating to Our Business and Industry

    The Company, its subsidiaries, and the MCs could be subject to breaches of security by hackers. Although we proactively employ multiple measures to defend our systems against intrusions and attacks, our measures may not prevent unauthorized access or use of sensitive data

  • 23% rewrittenRisks Relating to Our Business and Industry

    We have limited experience in providing management services to franchisee clinics located outside of Japan and we are subject to a variety of costs and risks due to our continued international expansion

  • 22% rewrittenRisks Relating to Our Business and Industry

    The MCs may fail to pay us in accordance with the terms of their franchise and management services agreements, at times necessitating action by us to attempt to compel payment

  • 21% rewrittenRisks Relating to Our Business and Industry

    If our business partners, independent contractors, suppliers, or franchisee and other alliance clinics fail to use ethical business practices and comply with applicable laws and regulations, our brand image could be harmed due to negative publicity beyond our own control

    Was: If our business partners, independent contractors, suppliers, or franchisee clinics fail to use ethical business practices and comply with applicable laws and regulations, our brand image could be harmed due to negative publicity beyond our own control

  • 20% rewrittenRisks Relating to Our Business and Industry

    Our franchisee and other alliance clinics may not be successful in competing in the cosmetic clinic industry

    Was: Our franchisee clinics may not be successful in competing in the cosmetic clinic industry

All 83 risk factors

Headings as the filing states them, in filing order.

Risks Relating to Our Business and Industry

  1. 01We are a holding company and depend upon our operating subsidiaries for our cash flows
  2. 02We may need additional capital, and we cannot be sure that additional financing will be available24% rewritten
  3. 03We may not grow our franchise system or we may lose business by failing to compete effectively or by failing to manage the reputation of our brand
  4. 04The financial performance of our franchisees and other alliance partners can negatively impact our business26% rewritten
  5. 05The interests of our franchisees and other alliance partners may conflict with ours or yours in the future and we could face liability from our franchisees and other alliance partners or related to our relationship with our franchisees and other alliance partners
  6. 06We could face liability from or as a result of our franchisees and other alliance partners
  7. 07We have limited control with respect to the operations of our medical corporation customers, which could have a negative impact on our business
  8. 08The relatives of our CEO account for two-thirds of the general meeting of members (or shain), which is the highest decision-making body in these MCs
  9. 09The challenging economic environment may affect our franchisees, with adverse consequences to us
  10. 10Our success depends in significant part on our and our licensees’ ability to establish, maintain and protect patents and other intellectual property rights and operate without infringing the intellectual property rights of others
  11. 11We have substantial franchisee concentration
  12. 12Our reputation and the trading price of our common stock may be negatively affected by adverse publicity or detrimental conduct against us
  13. 13We are a relatively young company with a short operating history, and we may not be able to sustain our rapid growth, effectively manage it or implement our business strategies
  14. 14If we fail to address any or all of these risks and challenges, our business may be materially and adversely affected
  15. 15Our franchisee and other alliance clinics may not be successful in competing in the cosmetic clinic industry20% rewritten
  16. 16The Company may face competition from senior management who cease working for it, and the Non-Competition Agreements (as defined below) may be unenforceable and expire two years following the Closing
  17. 17Any significant change in the customer reward program at our franchisee and other alliance clinics could have a negative impact on our business60% rewritten
  18. 18We depend on our and our franchisees’ and other alliance partners’ operating systems to operate. Any material disruption to or slowdown of our operating systems could cause delays in our management services, which could harm our brand and adversely affect our operating results
  19. 19The Company, its subsidiaries, and the MCs could be subject to breaches of security by hackers. Although we proactively employ multiple measures to defend our systems against intrusions and attacks, our measures may not prevent unauthorized access or use of sensitive data23% rewritten
  20. 20Uncertainties with respect to the development, and use of artificial intelligence in our business and products may result in harm to our business and reputationNew
  21. 21We may be compelled to undertake product recalls or take other actions, which could adversely affect our brand image and results of operations
  22. 22We may become subject to product liability claims or warranty claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims
  23. 23We have limited experience in providing management services to franchisee clinics located outside of Japan and we are subject to a variety of costs and risks due to our continued international expansion23% rewritten
  24. 24a legal system subject to undue influence or corruptionNew
  25. 25Our operations may be interrupted by utility shortages or stoppages, fire, natural disaster or other calamities at or near our facilities
  26. 26Our business and prospects depend significantly on our ability to build our Shonan Beauty Clinic brand
  27. 27Our employees, agents, business partners or subcontractors may engage in misconduct or other improper activities, which could cause us to lose contracts, expose us to damages, harm our reputation and diminish investor confidence in our company61% rewritten
  28. 28Any decline in the business of our business partners or the deterioration of our relationship with them could have a material adverse effect on our operating results
  29. 29Safety issues or public perceptions of safety issues concerning cosmetic services could have a material adverse impact on our business29% rewritten
  30. 30If our franchisee and other alliance clinics or our clinics in Vietnam or Singapore fail to comply with environmental and work safety laws and regulations, the Company and the franchisee and other alliance clinics could become subject to fines or penalties or incur costs that could harm our business
  31. 31If our business partners, independent contractors, suppliers, or franchisee and other alliance clinics fail to use ethical business practices and comply with applicable laws and regulations, our brand image could be harmed due to negative publicity beyond our own control21% rewritten
  32. 32Failure to safeguard personal information could subject us to penalties, damage our reputation and brand, and harm our business and results of operations32% rewritten
  33. 33As laws and regulations in Japan on the protection of privacy and data are constantly evolving, complying with new laws and regulations could cause us to incur substantial costs or require us to change our business practices in a manner materially adverse to our business
  34. 34Failure by the MCs and other independently operated clinics and physicians to comply with the Medical Care Act in Japan could subject us to penalties, damage our reputation and brand, and harm our business and results of operations
  35. 35We are subject to risks associated with strategic alliances or acquisitions. If we cannot manage the growth of our business or execute our strategies effectively, our business and prospects may be materially and adversely affected42% rewritten
  36. 36Our business could be adversely affected by trade tariffs or other trade barriers
  37. 37We and our subsidiaries have limited insurance coverage, which could subject us to significant costs and business disruption
  38. 38We are involved in litigation from time to time and, as a result, we could incur substantial judgments, fines, legal fees or other costs
  39. 39Any financial or economic crisis or perceived threat of such a crisis may materially and adversely affect our business, financial condition and results of operations42% rewritten
  40. 40We face risks related to natural disasters and health epidemics, which could significantly disrupt our operations
  41. 41If the landlords of our and our subsidiaries’ leased properties fail to properly maintain and renovate such premises, buildings or facilities in a timely manner or at all, the operation of our offices could be materially and adversely affected
  42. 42The MCs may fail to pay us in accordance with the terms of their franchise and management services agreements, at times necessitating action by us to attempt to compel payment22% rewritten
  43. 43Effective internal controls are necessary for us to provide reliable financial reports, prevent fraud and operate successfully as a public company. Section 404 of the Sarbanes-Oxley Act of 2002 requires that companies evaluate and report on their systems of internal control over financial reporting99% rewritten

Risks Related to Employee Matters

  1. 44If we cannot maintain our company culture as we grow, we could lose the innovation, teamwork, passion and focus on execution that we believe contribute to our success and our business may be harmed
  2. 45Our success depends on the continuing efforts of our key employees, including our senior management members and other key personnel. If we fail to hire, retain and motivate our key employees, we could lose the innovation, collaboration and focus that contribute to our business
  3. 46The failure to attract and retain additional qualified personnel could prevent us from executing our business strategy

Risks Related to Intellectual Property

  1. 47We and our subsidiaries may need to defend ourselves against claims of intellectual property infringement, which may be time-consuming and costly26% rewritten
  2. 48establish and maintain alternative branding for our brand and servicesNew
  3. 49Our or our subsidiaries’ intellectual property rights may not protect us effectively33% rewritten
  4. 50We cannot assure you that our or our subsidiaries’ pending patent applications will be granted. Even if our or our subsidiaries’ applications are successful, patents may be contested, circumvented or invalidated in the future
  5. 51The Company may not be able to protect its intellectual property rights throughout the world
  6. 52If we fail to protect, or incur significant costs in defending or enforcing our intellectual property and other proprietary rights, our business, financial condition and results of operations could be materially harmed

Risks Related to Government Regulation

  1. 53Failure to comply with laws and regulations could harm our business

General Risks

  1. 54Weakened global economic conditions may harm our industry, business and results of operations
  2. 55We are exposed to fluctuations in currency exchange rates26% rewritten
  3. 56Our actual operating results may differ significantly from our guidance and projections

Risk Relating to Ownership of Our Securities

  1. 57An active market for our securities may not develop, which would adversely affect the liquidity and price of our securities
  2. 58Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject the Company to additional trading restrictions
  3. 59The market price of our common stock may decline68% rewritten
  4. 60The market price of our common stock may be volatile, and you could lose all or part of your investment24% rewritten
  5. 61other events or factors, including those resulting from pandemics, natural disasters, war, acts of terrorism or responses to these eventsNew
  6. 62Because there are no current plans to pay cash dividends on the Company’s common stock for the foreseeable future, you may not receive any return on investment unless you sell your shares of the Company’s common stock at a price greater than what you paid for it
  7. 63The Company’s stockholders may experience dilution in the future
  8. 64If securities or industry analysts do not publish research or reports about the Company’s business, if they change their recommendations regarding the Company’s common stock or if the Company’s operating results do not meet their expectations, the Company’s common stock price and trading volume could decline
  9. 65Future sales, or the perception of future sales, by the Company or its stockholders in the public market following the Business Combination could cause the market price for the Company’s common stock to decline
  10. 66The Company may redeem unexpired public warrants prior to their exercise at a time that is disadvantageous for the Company’s warrant holders
  11. 67Our securities holders may face limitations in connection with the issuance of shares upon the exercise of our warrants, and additional state securities law requirements could apply if our securities were to become no longer listed on a national securities exchangeNew
  12. 68Substantial future sales of shares of our common stock could cause the market price of our common stock to decline
  13. 69If we fail to maintain effective internal control over financial reporting, the price of our securities may be adversely affected
  14. 70As an emerging growth company, our auditor is not required to attest to the effectiveness of our internal controls30% rewritten
  15. 71If a “penny stock” is sold to the investor in a fraudulent manner, the investor may be able to sue the persons and firms that committed the fraud for damagesNew
  16. 72We believe we will be considered a smaller reporting company and will be exempt from certain disclosure requirements, which could make our common stock less attractive to potential investors41% rewritten
  17. 73in the case of an issuer whose public float as calculated under paragraph (1) or (2) of this definition was zero or whose public float was less than $700 million, had annual revenues of less than $100 million during the most recently completed fiscal year for which audited financial statements are availableNew
  18. 74We incur significant costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives
  19. 75Delaware law and the Company certificate of incorporation and bylaws contain certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable56% rewritten
  20. 76These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in the Company’s board of directors or management
  21. 77Anti-takeover effects of certain provisions of Delaware state law could hinder a potential takeover of the Company44% rewritten
  22. 78Provisions in the Amended Charter and Delaware law may have the effect of discouraging lawsuits against the Company and its directors and officers71% rewritten
  23. 79Nothing in the Company’s certificate of incorporation or bylaws will preclude stockholders that assert claims under the Securities Act or the Exchange Act from bringing such claims in state or federal court, subject to applicable lawNew
  24. 80If the voting power of our capital stock continues to be highly concentrated, it may prevent you and other minority stockholders from influencing significant corporate decisions and may result in conflicts of interest
  25. 81In the event that our common stock price does not exceed the exercise price of the Private Placement Warrants during the period when the Private Placement Warrants are exercisable, the Private Placement Warrants may not have any value24% rewritten
  26. 82There must be a current registration statement in order for you to exercise the Private Placement Warrants62% rewritten
  27. 83Holders of our Private Placement Warrants will have no rights as a common stockholder until they acquire our common stock

Other SBC Medical Group Holdings 10-Ks

  • FY2024 10-K risk factors
    77 risks

    SBC Medical Group Holdings relies heavily on medical corporation franchisees in Japan, exposing it to key-person, regulatory, and credit risks.

    Filed Mar 28, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.